CD274 and cancer: Furthermore, it has been demonstrated that phosphorylation of PD-L1 at Thr285 and Thr290 by CK2 disrupted PD-L1 binding with speckle-type POZ protein and protected PD-L1 from proteasomal degradation in cancer [322].